◄ back to all posts

LLY: Eli Lilly & Co. Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 143,719.18
Enterprise Value ($M) 155,210.76
Book Value ($M) 4,092.90
Book Value / Share 4.28
Price / Book 34.78
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.15
Return on Assets (ROA) 0.19
Return on Equity (ROE) 0.85

Liquidity (mrq)
Quick Ratio 0.94
Current Ratio 1.22

Balance Sheet (mrq) ($M)
Current Assets 14,581.90
Assets 41,967.00
Liabilities 37,874.10
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 22,319.50
Operating Income n/a
Net Income 8,318.40
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted 8.89
Earnings Per Share Basic 8.93

Cash Flow Statement (mra) ($M)
Cash From Operations 4,836.60
Cash from Investing -8,082.90
Cash from Financing -8,082.90

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-14 13G Pnc Financial Services Group, Inc. 5.43
2020-02-12 13G/A Vanguard Group Inc 7.38 -6.26
2020-02-05 13G/A BlackRock Inc. 6.30 -11.71
2020-01-14 13G/A Lilly Endowment Inc 11.90 22.49
2019-02-12 13G/A Wellington Management Group Llp 4.37 -18.26
2018-12-06 13G/A Primecap Management Co/ca/ 4.85 -5.72

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-07-31 10-Q Quarterly Report – 10-Q
2020-05-01 10-Q Quarterly Report – 10-Q
2020-02-19 10-K Annual Report – 10-K
2019-10-25 10-Q Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-09-25 282,185 2,440,500 11.56
2020-09-24 221,468 3,424,300 6.47
2020-09-23 207,496 3,546,100 5.85
2020-09-22 197,452 2,926,300 6.75
2020-09-21 331,719 3,501,500 9.47

(click for more detail)

Similar Companies
JNJ – Johnson & Johnson KDMN – Kadmon Holdings, Inc.
LCI – Lannett Co., Inc. MNK – Mallinckrodt PLC
MRK – Merck & Co., Inc.


Financial data and stock pages provided by
Fintel.io




2018/07/06
◄ back to all posts

Retirement